NCT03260283View on ClinicalTrials.gov

Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

November 29, 2018

Study Completion Date

December 31, 2019

Conditions
Low Dose of Pethidine for Subarachnoid Anesthesia
Interventions
DRUG

Pethidine hydrochloride

In Group I patients will be administered with low dose of pethidine hydrochloride (0.4 mgkg-1) diluted into normal saline up to 2 ml of total volume in order to perform subarachnoid anesthesia for urologic operations

DRUG

Ropivacaine HCl Inj 7.5 MG/ML

In Group II patients will be administered with 2 ml of ropivacaine (0.75%)

DRUG

Fentanyl

15 mcg of fentanyl will be added to the solution in order to perform subarachnoid anesthesia for urologic operations

Trial Locations (1)

Unknown

"Anticancer Hospital of Athens Saint Savvas", Athens

All Listed Sponsors
lead

Saint Savvas Anticancer Hospital

OTHER

NCT03260283 - Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations. | Biotech Hunter | Biotech Hunter